NSC |
Compound |
Enrichment |
Correlation |
NSC 329261 |
Null |
0.00286159651545682 |
0.12869349 |
NSC 40273 |
Null |
0.00286159651545682 |
0.095626217 |
NSC 618939 |
Camptothecin Derivative |
0.00286159651545682 |
0.61205938 |
NSC 643006 |
Null |
0.00286159651545682 |
0.57767142 |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.00286159651545688 |
0.48698221 |
NSC 670664 |
Null |
0.00286159651545688 |
0.21273523 |
NSC 681636 |
Camptothecin Derivative |
0.00286159651545688 |
0.63824387 |
NSC 716258 |
Null |
0.00286159651545688 |
0.063278871 |
NSC 725774 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.00286159651545688 |
0.50729919 |
NSC 725775 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.00286159651545688 |
0.56396105 |